Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fingolimod and Risk of Skin Cancer Among Individuals with Multiple Sclerosis: a Population-based Cohort Study

NCT06705608 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06705608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06705608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fingolimod and Risk of Skin Cancer Among Individuals with Multiple Sclerosis: a Population-based Cohort Study
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Completed
Start date
January 1, 2003
Completion date
December 31, 2020
Enrollment
4,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis (ms) - relapsing-remitting, skin cancer, skin cancer melanoma, skin cancer, squamous cell, skin cancers - basal cell carcinoma